Background: Staphylococcal scalded skin syndrome (SSSS) is a rare toxin-mediated skin disease caused by Staphylococcus aureus and seen in infants and children younger than 5 years. Objectives: The supportive role of skin substitutes in SSSS is stressed as a new and relatively unknown method. Methods: Retrospective observational case-series study, in neonates and young infants diagnosed with SSSS. Results: Seven infants with SSSS, treatment with antibiotics, skin substitutes, strict pain relief strategy and prognosis were described. One of them was severely affected and deceased. Conclusion: This study describes 7 infants with SSSS and stresses the important role of skin substitutes as Omiderm® and Suprathel® as valuable adjuvant treatment modality. Copyright

Guidelines, Infants, Skin substitutes, Staphylococcal infections, Staphylococcal scalded skin syndrome, neonates
dx.doi.org/10.1159/000317997, hdl.handle.net/1765/34554
Neonatology: fetal and neonatal research
Erasmus MC: University Medical Center Rotterdam

Baartmans, M.G.A, Dokter, J, den Hollander, J.C, Kroon, A.A, & Oranje, A.P. (2011). Use of skin substitute dressings in the treatment of staphylococcal scalded skin syndrome in neonates and young infants. Neonatology: fetal and neonatal research, 100(1), 9–13. doi:10.1159/000317997